2196.HK 600196.SHG
Legend Biotech is a biotech

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) said on Monday that Shanghai Fosun High Technology, a subsidiary of Fosun International (0656.HK), has pledged 198 million shares of the Shanghai-listed A-shares it holds in Fosun Pharma to banking giant ICBC. The pledged shares account for 7.4% of Fosun Pharma’s total, and Fosun High Tech will use proceeds raised through the share pledge to repay debts.

Together with previously pledged shares, Fosun has pledged a total of nearly 720 million of Fosun Pharma’s A-shares, accounting for 26.65% of its total.

Fosun Pharma said agreements involving 433 million of its pledged shares will expire within one year, accounting for approximately 16.2% of the company’s total shares, involving an amount of 4.36 billion yuan.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Bright Smart is a brokerage

Mainland regulators trip up Ant Group – again

Hong Kong’s Bright Smart Securities says its plan to be acquired by Ant is progressing on schedule, but a media report suggests the deal may face greater regulatory scrutiny Key…